Lung Ambition Alliance Company Profile, Contacts & Intelligence

Lung Ambition Alliance Overview

The Lung Ambition Alliance (LAA) is a global coalition currently comprised of three partners, each with distinct and world-leading expertise in lung cancer: AstraZeneca, Guardant Health and the Global Lung Cancer Coalition. The LAA was established in 2019 to accelerate advances in lung cancer survival and improve patient outcomes. We are at a critical moment for the lung cancer community. The disease caused an estimated 1.8 million deaths in 2020 alone, or approximately one-fifth of all deaths from cancer. Without coordinated global action, lung cancer deaths are projected to increase to 3 million by 2040. Our goal is ambitious: to one day eliminate lung cancer as a cause of death. In pursuit of this goal, our focus is three-fold on increasing lung cancer screening and diagnosis; delivering innovative medicines to patients, especially earlier in their care when there is greater potential for cure; and improving quality care through patient advocacy and policymaker collaboration.

Headquarters

Cambridge, Cambridgeshire, United Kingdom

Website

www.lungambitionalliance.com

Industry

Public Health

Founded

2019

NAICS

Administration of Public Health Programs

Compare Similar Companies to Lung Ambition Alliance

Explore companies in related markets and compare their industry and employee estimates.